These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23134201)

  • 1. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
    Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
    J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
    Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
    J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthogranulomatous cholecystitis: a premalignant condition?
    Ghosh M; Sakhuja P; Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
    Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
    Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
    Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
    Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
    Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
    Rao RV; Kumar A; Sikora SS; Saxena R; Kapoor VK
    Trop Gastroenterol; 2005; 26(1):31-3. PubMed ID: 15974235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogranulomatous cholecystitis: A retrospective cohort study of 240 patients.
    Xiao J; Zhou R; Zhang B; Li B
    Cancer Med; 2022 Jan; 11(1):176-182. PubMed ID: 34837350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
    Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
    Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5.
    Yu H; Yu TN; Cai XJ
    Chin Med J (Engl); 2013 Aug; 126(16):3044-7. PubMed ID: 23981609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
    Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
    Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
    Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.
    Suzuki H; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
    World J Gastroenterol; 2015 Sep; 21(35):10166-73. PubMed ID: 26401081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy.
    Jayalakshmi K; Sonkar K; Behari A; Kapoor VK; Sinha N
    NMR Biomed; 2011 May; 24(4):335-42. PubMed ID: 22945290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthogranulomatous cholecystitis (XGC): a clinicopathological study of 21 cases.
    Solanki RL; Arora HL; Gaur SK; Anand VK; Gupta R
    Indian J Pathol Microbiol; 1989 Oct; 32(4):256-60. PubMed ID: 2632411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of E-cadherin gene in gall bladder cancer and its precursor lesions.
    Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agrawal S
    Virchows Arch; 2010 May; 456(5):507-14. PubMed ID: 20376482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
    Deng YL; Cheng NS; Zhang SJ; Ma WJ; Shrestha A; Li FY; Xu FL; Zhao LS
    World J Gastroenterol; 2015 Nov; 21(44):12653-9. PubMed ID: 26640342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-pathological study of xanthogranulomatous cholecystitis].
    Kitagawa S; Nakagawa M; Yamada T; Mori Y; Simizu H; Rin S; Kurumaya H
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1001-10. PubMed ID: 2233654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is xanthogranulomatous cholecystitis the most difficult for laparoscopic cholecystectomy?
    Kim JH; Jeong IH; Yoo BM; Kim JH; Kim MW; Kim WH
    Hepatogastroenterology; 2009; 56(91-92):597-601. PubMed ID: 19621662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
    Agarwal AK; Kalayarasan R; Javed A; Sakhuja P
    J Gastrointest Surg; 2013 Jul; 17(7):1257-64. PubMed ID: 23615807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.